##semicolon##
мультифокал атеросклероз, пилакчалар, артерия.##submission.citations##
Асадуллаев М.М., Рахимбаева Г.С., Вахабова Н.М. Значение гендерных и возрастных факторов в патогенезе ишемического инсульта в современной медицине // Вестн. ТМА. – 2020. – №6. – С. 25-31.
Габриелян А.В., Чевелюк О.В. Особенности реваскуляризации миокарда при мультифокальном атеросклерозе с поражением коронарных артерий и артерий нижних конечностей // Укр. журн. сердечно-сосуд. хир. – 2024. – Т. 32, №4. – С. 14-19.
Aboyans V., Ricco J.B., Bartelink M.L. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases // Eurор. Heart J. – 2017.
Asadullaev M.M., Vakhabova N.M. Risk factors and background diseases in different pathogenetic subtypes of ischemic stroke // Int. J. Orange Techn. – 2020. – Vol. 2, №10. – Р. 86-88.
Asadullayev M.M., Vakhabova N.M. Epidemiology and structure of stroke in India // Болезни кровообращения. – 2025. – №1 (3). – С. 93-98.
Cai J. et al. Polyvascular Atherosclerosis in the General Population: The PRECISE Study // J.A.M.A. Netw Open. – 2022.
Collet J.P. et al. 2020 ESC Guidelines for ACS management // Eurор. Heart J. – 2020.
Criqui M.H. et al. The prevalence and prognostic value of polyvascular disease: MESA // JACC. – 2019.
Gao J., Cheng Y. Ultrasound-based prevalence of polyvascular disease and its association with adverse outcome in patients undergoing coronary artery bypass grafting // Sci. Progress. – 2024. – Vol. 107, №4.
Gkolfinopoulou C. et al. Polyvascular disease and MACE risk // Atherosclerosis. – 2021.
Hiatt W.R. et al. Rivaroxaban in Peripheral Artery Disease – after Revascularization // New Engl. J. Med. – 2020. – Vol. 382. – Р. 1994-2004.
Libby P. Inflammation in Atherosclerosis: From Theory to Practice // Cell. – 2021.
Lipid Cardio Study Investigators. Polyvascular atherosclerosis and renal dysfunction increase the odds of cognitive impairment in vascular disease: findings of the LipidCardio study // Europ. J. Med. Res. – 2024. – Vol. 29. – Р. 141.
Musiałek P., Montauk L., Saugnet A. et al. The prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease // Kardiol. Polska. – 2019. – Vol. 77, №10. – Р. 899-901.
Parton A., McGilligan V., OKane M. et al. Computational Modelling of Atherosclerosis. 2015.
Polonetsky O.L., Polonetsky L.Z. Endothelial Dysfunction and Atherosclerosis // Med. News. – 2012. – №6.
Safian R.D., Textor S.C. Renal-Artery Stenosis // New Engl. J. Med. – 2001. – Vol. 344. – Р. 431-442.
Shah P.K. Plaque Vulnerability and Inflammation // J. Amer. Coll. Cardiol. – 2020.
Vakhabova N.M., Asadullaev M.M. Lipoproteins and their receptors association in ischemic stroke // J. Angiother. – 2024. – Vol. 8, №7. – Р. 1-6.
Van Kuijk J.-P. et al. Polyvascular Disease: Clinical Outcomes and Predictors // Eurор. J. Vasc. Surg. – 2020.
Virani S.S., Smith S. et al. Heart Disease and Stroke Statistics – 2023 // Circulation. – 2023.
Weissler E.H. et al. Polyvascular Disease: a narrative review of risk factors, clinical outcomes and treatment // Atherosclerosis. – 2020. – Vol. 315. – Р. 102-113.
Xu S. et al. Vasa Vasorum, Inflammation, and Plaque Progression // Arteriosc. Thromb. Vasc. Biol. – 2015.
Yazdani S. et al. Intravascular Imaging of Vulnerable Plaques // Nat. Rev. Cardiol. – 2021.
Zhu C.-Y., Zhang J.-N., Tse Y.-K. et al. Clinical Characteristics and Prognosis of Vascular Disease in Valvular Heart Surgery: A Multi-Centre Study // Global Heart. – 2025. – Vol. 20, №1. – Р. 71.